Cytostatic activity of antiviral acyclic nucleoside phosphonates in rodent lymphocytes

Toxicology and Applied Pharmacology

Volumn 192, Issue 3, 2003, Pages 246-253

  Zídek, Zdeněk ^a   Potměšil, Petr ^a   Holý, Antonín ^b  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

^b INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

Author keywords

Acyclic nucleoside phosphonates; Adefovir; Cytostatic activity; Tenofovir

Indexed keywords

2,6 DIAMINOPURINE DERIVATIVE; 9 [2 (PHOSPHONOMETHOXY)ETHYL]PURINE DERIVATIVE; ACYCLIC NUCLEOSIDE; ADEFOVIR; ADEFOVIR DIPIVOXIL; ADENINE DERIVATIVE; ANTIVIRUS AGENT; CYTOSTATIC AGENT; MITOGENIC AGENT; PHOSPHONIC ACID DERIVATIVE; TENOFOVIR; TENOFOVIR DISOPROXIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOSTASIS; DRUG EFFECT; ENANTIOMER; FEMALE; IC 50; LYMPHOCYTE; MOUSE; NONHUMAN; RAT; RODENT; SPLEEN CELL;

CONGRIDAE; DNA VIRUSES; RODENTIA;

EID: 0142219786     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-008X(03)00215-1     Document Type: Article

References (33)

1. Balzarini J., Hao Z., Herdewijn D., Johns D.G., DeClrecq E. Intracellular metabolism and mechanism of anti-retrovirus action of 9-(2-phosphonylmethoxyethyl)adenine (PMEA), a potent anti-HIV compound. Proc. Natl. Acad. Sci. USA. 88:1991;1499-1503.
2. Balzarini J., Holý A., Jindřich J., Naesens L., Snoeck R., Schols D., De Clercq E. Differential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(2- phosphonomethoxypropyl)-2,6-diaminopurine . Antimicrob. Agents Chemother. 37:1993;332-338.
3. Balzarini J., Perno C.-F., Schols D., De Clercq E. Activity of acyclic nucleoside phosphonate analogues against human immunodeficiency virus in monocyte/macrophages and peripheral blood lymphocytes. Biochem. Biophys. Res. Commun. 178:1991;329-335.
4. Cihlář T., Rosenberger I., Votruba I., Holý A. Transport of 9-(2-phosphonomethoxyethyl)adenine across plasma membrane of HeLa S3 cells is protein mediated. Antimicrob. Agents Chemother. 39:1995;117-124.
5. Collier, A.C., Coombs, R.W., Nienow, J., Paradise, M., Yang, H.H., Troxel, S., Boggs, J., Ebeling, D., Jaffe, H.S., Corey, L., 1993. Phase I/II study of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) in advanced HIV infection. The First National Conference on Human Retroviruses and Related Infections, Bethesda, MD.
6. De Clercq E. Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox. and adenovirus) infections. Verh. K. Acad. Geneeskd. Belg. 58:1996;19-47.
7. de Waal Malefyt R., Haanen J., Spits H., Roncarolo M.G., de Velde A., Figdor C., Johnson K., Kastelein R., Yssel H., de Vries J. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174:1991;915-924.
8. Hatse S., Naesens L., De Clercq E., Balzarini J. N-6-cyclopropyl-PMEDAP a novel derivative of 9-(2-phosphonomethoxyethyl)-2,6-diaminopurine (PMEDAP) with distinct metabolic, antiproliferative, and differentiation-inducing properties . Biochem. Pharmacol. 58:1999;311-446.
9. Ho H.-T., Woods K.L., Konrad S.K., DeBoeck H., Hitchcock J.M. Cellular metabolism and enzymatic phosphorylation of 9-(2-phosphorylmethoxyethyl) guanine (PMEG), a potent antiviral agent. Block T.M. Innovations in Antiviral Development and the Detection of Virus Infection. 1992;159-166 Plenum Press, New York.
10. Holý, A., 2002. Synthesis and biological activity of isopolar acyclic nucleotide analogs, in: Chu, C.K. (Ed.), Recent Advances in Nucleosides: Chemistry and Chemotherapy, Elsevier, pp. 167-238.
11. 6-substituted 6-aminopurines. Antiviral Res. 26:1995;A231-A231. (Abstract).
12. 6-substituted adenines, 2,6-diaminopurines and related compounds. Collect. Czech. Chem. Commun. 66:2001;1545-1592.
13. Kramata P., Downey K.M. 9-(2-Phosphonomethoxyethyl) derivatives of purine nucleotide analogs a comparison of their metabolism and interaction with cellular DNA synthesis . Mol. Pharmacol. 56:1999;1262-1270.
14. Kramata P., Votruba I., Otová B., Holý A. Different inhibitory potencies of acyclic phosphonomethoxyalkyl nucleotide analogs toward DNA polymerases a, d and e. Mol. Pharmacol. 49:1996;1005-1011.
15. Krejčová R., Horská K., Votruba I., Holý A. Phosphorylation of purine (phosphonomethoxy)alkyl derivatives by mitochondrial AMP kinase (AK2 type) from L1210 cells. Collect. Czech. Chem. Commun. 65:2000;1653-1668.
16. Lalezari J.P., Drew W.L., Glutzer E.C.J., Miner D., Flaherty J., Fisher P.E., Cundy K., Hannigan J., Martin J.C., Jaffe H.S. (S)-1-[3-hydroxy-2- (phosphonomethoxy)propyl]cytosine (Cidofovir) results of a phase I/II study of a novel antiviral nucleotide analogue . J. Infect. Dis. 171:1995;788-796.
17. Lin J.C., De Clercq E., Pagano J.S. Inhibitory effects of acyclic nucleoside phosphonate analogs, including (S)-1-(3-hydroxy-2- phosphonomethoxypropyl)-cytosine, on Epstein-Barr virus replication. Antimicrob. Agents Chemother. 35:1991;2440-2443.
18. Merta A., Votruba I., Rosenberg I., Otmar M., Hřebabecký H., Bernaerts R., Holý A. Inhibition of herpes simplex virus DNA polymerase by diphosphates of acyclic phosphonylmethoxyalkyl nucleotide analogues. Antiviral Res. 13:1990;209-218.
19. Naesens L., Balzarini J., DeClrecq E. Therapeutic potential of PMEA as an antiviral drug. Rev. Med. Virol. 4:1994;147-159.
20. Neyts J., De Clercq E. Mechanism of action of acyclic nucleoside phosphonates against herpes virus replication. Biochem. Pharmacol. 47:1994;39-41.
21. Neyts J., Snoeck R., Schols D., Balzarini J., De Clercq E. Selective inhibition of human cytomegalovirus DNA synthesis by (S)-1-(3-hydroxy-2- phosphonomethoxypropyl)cytosine [(S)-HPMPC] and 9-(1,3-hydroxy-2-propoxymethyl) guanine (DHPG). Virology. 179:1990;41-50.
22. Palu G., Stefanelli S., Rassu M., Parolin C., Balzarini J., DeClercq E. Cellular uptake of phosphonomethoxyalkyl derivatives. Antiviral Res. 16:1991;115-119.
23. Perrillo R., Schiff E., Yoshida E., Statler A., Hirsch K., Wright T., Gutfreund K., Lamy P., Murray A. Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants. Hepatology. 32:2000;129-134.
24. Pisarev V.M., Lee S.-H., Connelly M.C., Fridland A. Intracellular metabolism and action of acyclic nucleoside phosphonates on DNA replication. Mol. Pharmacol. 52:1997;63-68.
25. Reymen D., Naesens L., Balzarini J., Holý A., Dvořá ková H., De Clercq E. Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6. Antiviral Res. 28:1995;343-357.
26. Taniguchi T., Minami Y. The IL-2/IL-2-receptor system a current overview . Cell. 73:1993;5-8.
27. Thormar H., Balzarini J., Holý A., Jindřich J., Rosenberg I., Debyster Z., Desmyter J., De Clercq E. Inhibition of visna virus replication by 2′,3′-dideoxynucleosides and acyclic nucleoside phosphonate analogs. Antimicrob. Agents Chemother. 37:1993;2540-2544.
28. Thormar H., Georgsson G., Palsson P.A., Balzarini J., Naesens L., Torsteinsdottir S., De Clercq E. Inhibitory effect of 9-(2- phosphonomethoxyethyl)adenine on visna virus infection in lambs a model for in vivo testing of a candidate anti-human immunodeficiency virus drugs . Proc. Natl. Acad. Sci. USA. 92:1995;3283-3287.
29. Tsai C.-C., Follis K.E., Sabo A., Beck T.W., Grant R.F., Bischofberger N., Benveniste R.E., Black R. Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine. Science. 270:1995;1197-1199.
30. Votruba I., Trávníček M., Rosenberg I., Otmar M., Merta A., Hřebabecký H., Holý A. Inhibition of avian myeloblastosis virus reverse transcriptase by diphosphates of acyclic phosphonylmethyl nucleotide analogues. Antiviral Res. 13:1990;287-293.
31. Yang H., Datema R. Prolonged and potent therapeutic and prophylactic effects of (S)-1-[(3-hydroxy-2-phosphonylmethoxy)propyl]cytosine against herpes simplex virus type 2 infections in mice. Antimicrob. Agents Chemother. 35:1991;1560-1596.
32. Yang R., Lu C. Developmental activity variations of DNA polymerase alpha, delta, epsilon in mouse forebrains and spleens. Science. 38:1995;1237-1245.
33. Zídek Z., Holý A., Franková D. Immunomodulatory properties of antiviral acyclic nucleotide analogues cytokine stimulatory and nitric oxide costimulatory effects . Int. J. Immunopharmac. 19:1997;587-597.